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Abstract
Objectives
MRSA poses a considerable public health threat to the community. The objectives of this
study were to assess the prevalence of MRSA carriage and determine factors that were
associated with MRSA carriage among outpatients who had used antibiotics in the previous
three months and who lived in a high-density livestock farming area along the Dutch-Ger-
man border.
Methods
Cross-sectional prevalence study carried out between November 2011 and June 2012.
Nasal swabs and questionnaires were collected in patients (>4 years) who had used antibi-
otics in the previous three months from twelve Dutch General Practitioners (GPs), seven
German GPs and two German outpatient urologists. To assess nasal carriage, swabs were
analyzed using selective MRSA agars after broth enrichment. MRSA positive samples were
spa typed.
Results
Data were collected from 513 GP outpatients in the Netherlands, 261 GP outpatients in Ger-
many and 200 urologist outpatients in Germany. The overall prevalence of MRSA carriage
was 0.8%, 1.1% and 2.0%, respectively. In the GP outpatient populations, the prevalence
was similar in both countries (0.8% and 1.1%, respectively, p = 0.879), all spa types were
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indicative for livestock-associated MRSA (4xt011 in the Netherlands; 2xt034 and t011 in
Germany) and being a farmer, living on or near (<5km) to a farm were associated with
MRSA carriage. In the urologist outpatient population, the prevalence was higher (2.0%), all
spa types were indicative for healthcare-associated MRSA (t068, t032, t003, t10231) and
being a farmer, living on or near to a farm were factors not associated with MRSA carriage.
Conclusions
The prevalence of MRSA carriage in these community outpatient populations along the
Dutch-German border was low. There were striking similarities in livestock-associated
MRSA carriage and clonal spread in the outpatient populations seeing their GP in both
countries. In contrast, urologist outpatients in Germany were colonized with spa types indic-
ative of healthcare-associated MRSA.
Introduction
The epidemiology of Methicillin-resistant Staphylococcus aureus (MRSA) in Europe has
changed since the 1990s. Next to healthcare-associated (HA)- or community-acquired (CA)
strains, livestock-associated (LA) MRSA have emerged as a third entity. The most important
LA-MRSA circulating among humans belong to clonal complex 398 (CC398) as defined by
multilocus sequence typing (MLST), with the reservoir for this pathogen mainly found in pigs
and cattle [1], and more recently, in poultry [2]. Using S. aureus protein A (spa) sequence typ-
ing, MRSA associated with CC398 are characterized by spa types t011, t034, t108 and close rel-
atives [3]. Persons with LA-MRSA were first detected in the Netherlands in 2003 [4] and soon
after in Germany [5].
Several studies have shown that persons in direct contact with livestock, especially pigs and
veal calves, have an increased risk for MRSA [3,4,6]. General practitioners (GPs) are concerned
that some common infections (e.g. skin and soft-tissue infections and urinary tract infections)
could increasingly be caused by MRSA and thus become more difficult to treat [7] as described
after the emergence of CA-MRSA in the USA [8]. As MRSA is associated with higher mortality
and costs, it is of utmost importance that the spread of MRSA is controlled and prevented
[9,10].
The objective of this study was to assess the prevalence and factors that were associated with
MRSA carriage among persons who visited their GP and had used antibiotics in the previous
three months. To our knowledge this is the first study carried out in persons who had used
antibiotics, and we expected a higher prevalence of MRSA as studies have shown a causal link
between bacterial resistance and antibiotic usage at an individual patient level [7, 11], with the
greatest effect in the month immediately after treatment and probable persistence for up to 12
months [7]. The research was carried out in an area of high density livestock farming (see Fig
1), which increased the risk of MRSA carriage [5,6], specifically, along the border of the Neth-
erlands (Gelderland, Brabant, Limburg; Dutch region) and Germany (Münsterland, Arnsberg
in North Rhine-Westphalia; German region).
Methods
A cross-sectional prevalence study was carried out in each region between November 2011 and
June 2012.
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Ethics Statement
In the Netherlands, the study protocol was submitted to the Medical Ethical Review Board of
the Radboud University Nijmegen Medical Center, which indicated that ethical review was not
required (registration number 2011/129) and in Germany it was approved by the Medical Ethi-
cal Commission of the Ärztekammer Westfalen-Lippe (2006-268-f-S). All participants pro-
vided written informed consent to participate in the study. For children participating in the
study, written informed consent was obtained from a parent or guardian. The ethics commit-
tees approved this consent procedure.
Sample size calculation
Our objectives was to determine a 50% difference in the prevalence of MRSA carriage rates
between the two regions. When planning the study, we did not know the prevalence of MRSA
and we assumed that persons who had used antibiotics in the previous 3 months would have a
higher rate of carriage [7,11]. To determine a 50% difference in the prevalence of MRSA car-
riage rates between the two regions (assuming a 4% carriage rate in the Dutch region) with a
95% precision, 1,000 patients were required in each region.
Recruitment of the participating GPs and outpatient urologists
We assumed it would be feasible to collect 100 nasal swabs per GP and therefore included 10
GPs in each region. In the Netherlands, the GPs were recruited via the GP network of the
Department of Primary and Community Care at the Radboud university medical center (3
GPs) and by randomly contacting GPs by telephone in the three provinces along the Dutch-
German border (9 GPs).
Fig 1. Map of the Netherlands and the German federal state of North Rhine-Westphalia: pig-density
rates (pigs per km2) and location of GPs and outpatient urologists. Note: The pig-density data for the
Netherlands is from 2012 and for North Rhine-Westphalia it is from 2010 (the most recent data available for
both countries).
doi:10.1371/journal.pone.0139589.g001
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In Germany, the physicians in primary care were asked to participate via the Regional Orga-
nization for Physicians in Primary Care; all physicians who responded (7 GPs and 2 urologists)
were contacted by the study centre based at the University Hospital Münster and were included
without further selection. The two outpatient urologists were included in the study as it was dif-
ficult to recruit GPs in the German study region and, in contrast to the Netherlands, access to
specialized outpatient urologist care in Germany is available to all patients with urological
symptoms (a referral by the patient’s GP is not required).
Data collection
The persons included in the study were four years and older, had used antibiotics during the
previous three months, were not terminally ill and were not immuno-compromised. The GPs /
outpatient urologists used the patient’s medical dossier to assess whether patients had received
an antibiotic in the previous three months and these persons were invited to participate in the
study. A person who was prescribed antibiotics at the consultation, but who had not used anti-
biotics during the previous three months, was excluded from the study.
All persons who participated in the study were recruited by the practicing GP/outpatient
urologist and met the study inclusion criteria. Once the GP/outpatient urologist had assessed
whether the patient was willing to enter the study, the person was asked to complete an
informed consent form. The GP, outpatient urologist, nurse or practice researcher then took a
swab from the anterior nostrils and completed a short questionnaire (8 questions) together
with the participant (S1 File). The first question covered the type of antibiotics used in the pre-
vious three months and the medical indication for prescribing them; the other questions cov-
ered basic demographic information and risk factors for MRSA carriage. No data was collected
on patients who refused to participate in the study but GPs/outpatient urologists were asked to
continue the study until they reached a target number of 100 patients. All patient-related data
on the swabs and questionnaire were anonymized using a study code only known to the GP/
outpatient urologist.
Collection of the nose swabs and study questionnaires
Nasal swabs (a dry swab applied to both nostrils) and questionnaires were collected in persons
treated by the twelve Dutch GPs, seven German GPs and two German outpatient urologists.
The GPs participating in the study in both regions had difficulties reaching the target of 100
nose swabs during the data collection period as fewer patients than planned were eligible for
inclusion in the study and organizational issues (e.g. the active inclusion of patients by GPs tai-
lored off over time). The study finally collected 513 nose swabs in the Netherlands (range: 7 to
79 per GP) and 461 in Germany (range: 8 to 70 per GP and 100 for the two outpatient
urologists).
Microbiological testing
The swabs and questionnaires were sent to a central laboratory in each country for microbio-
logical testing and were then returned to the study co-ordination centre at the Radboud univer-
sity medical center. The microbiological laboratories in the Netherlands and Germany used a
harmonized diagnostic protocol: swabs were enriched overnight at 36°C in Mueller-Hinton
broth containing 6.5% sodium chloride; 10 μl of this sample were streaked onto a chromogenic
medium for the detection of MRSA (bioMérieux, Marcy l’Etoile, France) as well as Columbia
blood agar (for the detection of methicillin-susceptible S. aureus (MSSA)) and incubated for
18-24h (36°C). Suspicious colonies were confirmed as MRSA using VITEK-2 automated sys-
tems (with EUCAST breakpoints for susceptibility testing), nuc-PCR andmecA-PCR. All
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MRSA isolates were subjected to S. aureus protein A (spa) sequence-typing [12]. In Germany,
all swabs were tested for MRSA and MSSA, whilst in the Netherlands all swabs were tested for
MRSA (513 swabs) and testing for MSSA was only added to the routine testing protocol at the
end of the study (82 swabs).
Statistical analysis
The statistical analysis was carried out by IBM SPSS statistics 2.0 with descriptive and bivariate
statistics. P-values were derived from Chi-square tests.
Results
A total of 974 persons were included in the study and 11 (1.1%) were MRSA carriers. The prev-
alence of MRSA carriage was 0.8% in the Dutch GP outpatients, 1.1% in the German GP outpa-
tients and 2.0% in the German urologist outpatients (none of these differences were significant:
p = 0.879, p = 0.714, p = 0.319). The prevalence of S. aureus carriage (MSSA and MRSA) was
31% in the Netherlands (based on the sub-sample of 82 swabs) and 24% in Germany (based on
all 461 swabs).
In the Dutch region the median age of all study participants was higher than in the German
region (58.3 versus 53.6 years) and this difference was especially strong for the GP outpatients
(58.3 versus 50.3). More females than men participated in the study in both countries and
more than 10% of persons were healthcare workers among the GP outpatients (Table 1).
Among GP outpatients, the percentage of farmers (3.3% and 3.8%, respectively) and patients
who were hospitalized in the previous six months was very similar. As expected, the German
urologist outpatients mainly saw patients who had received antibiotics to treat a urinary tract
infection (98.5%) in the previous three months. None of the urologist outpatients were
farmers.
Table 2 shows the prevalence of MRSA carriage stratified by country and factors associated
with MRSA carriage. Only factors that were significant are presented in the Table and we pres-
ent some grouped categories due to the small number of MRSA cases. Among the GP outpa-
tients, 1) being a Farmer; 2) being a Farmer and/or Living on a farm; 3) being a Farmer and/or
Living on a farm and/or Living near to a farm (<5 km), were factors that were significantly
associated with MRSA carriage in both countries. We could not identify any factor in the ques-
tionnaire that was significantly associated with MRSA carriage in the urologist outpatients in
Germany, but this may have been a result of the smaller sample size in this patient group.
We also assessed whether MRSA carriage was associated with an antibiotic type or antibiotic
usage in the previous three months (calculated by multiplying the dose by the treatment dura-
tion and the number of tablets per day; with usage classified as ‘high’ or ‘low’ based on a 2500
mg cut-off). We found no significant associations for the antibiotic types. For antibiotic usage,
we found a significant association with MRSA carriage for GP patients in the Netherlands
(p = 0.033), but not for GP (p = 0.169) or urologist (p = 0.140) patients in Germany.
Table 3 presents the characteristics of all MRSA cases detected in this study. In the Dutch
region we found only spa types indicative for LA-MRSA CC398 (n = 4; t011), in the German
region four HA- (t003, t032, t068 and t10231) and three LA-MRSA (t011, n = 1; t034, n = 2).
All cases among GP outpatients were associated with LA-MRSA and all cases in the urologist
outpatients in Germany were caused by HA-MRSA strains, known to circulate in the German
healthcare system [13]. In total, of seven persons with LA-MRSA, five were farmers and all
were GP outpatients. Three of four German urologist outpatients colonized with HA-MRSA
strains were either healthcare workers or had been hospitalized within the past six months
before the investigation.
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Table 1. Characteristics of participating patients: Dutch region (Gelderland, Brabant, Limburg) and German region (North Rhine-Westphalia).
Characteristic Description Dutch region German region Total
GP
outpatients
GP
outpatients
Urologist
outpatients
Total Number 513 261 200 461
Mean age Years 58.3 50.3 57.8 53.6
Female Yes 64.9% 66.3% 60.0% 63.6%
Healthcare worker Yes 11.9% 15.7% 5.5% 11.3%
Farmer Yes 3.3% 3.8% 0.0% 2.2%
Hospitalized last 6 months Yes 15.8% 16.1% 30.0% 22.1%
MRSA positive Yes 0.8% 1.1% 2.0% 1.5%
Health reason for which antibiotics were prescribed in
previous three months:
Urinary Tract Infection 23.6% 16.5% 98.5%
Respiratory Infection 23.6% 16.5% 98.5% 52.1%
Sinusitis/pharyngitis/
laryngitis
35.6% 44.8% 0.5% 25.6%
Others 10.4% 26.4% 0.0% 15.0%
30.3% 12.3% 1.0% 7.4%
Antibiotic1 prescribed in previous three months: Broad-spectrum penicillin 11.1% 5.7% 0.5%
Doxycycline/tetracycline 29.3% 6.1% 2.5% 3.5%
TMP, SMZ and TMP/SMZ 4.6% 5.7% 8.5% 4.6%
Macrolides 7.9% 27.6% 0.0% 6.9%
Small-spectrum penicillin 24.6% 27.6% 1.0% 15.6%
Fluoroquinolones 21.4% 12.6% 75.0% 16.1%
Cephalosporines 0.2% 10.0% 10.5%
Others 0.6% 4.6% 2.0% 3.5%
1 Based on the ﬁrst-reported antibiotic (93% of patients reported only one antibiotic in the previous 3 months): Broad-spectrum penicillin (amoxicillin/
clavulanic acid); Small-spectrum penicillin (benzylpenicillin, amoxicillin, feneticillin, ﬂucloxacillin); Cephalosporines (cefuroxime, cefpodoxime, ceftibuten,
ceﬁxime), TMP (trimethoprim); SMZ (sulfamethoxazole)
doi:10.1371/journal.pone.0139589.t001
Table 2. Prevalence of MRSA carriage by population group and factors associated with MRSA carriage1: Dutch region (Gelderland, Brabant, Lim-
burg) and German region (North Rhine-Westphalia).
Factor Dutch region—GP2
outpatients
German region—GP
outpatients
German region—urologist
outpatients
Germany total
N MRSA
positive n (%)
p-
value
N MRSA
positive n (%)
p-
value
N MRSA
positive n (%)
p-
value
MRSA
positive n (%)
Total 513 4 (0.8) 261 3 (1.1) 200 4 (2.0) 7 (1.5)
Farmer3 Yes 17 3 (17.6) <0.000 10 2 (20.0) 0.002 0 0 (0.0) - 2 (20.0)
No 486 1 (0.2) 251 1 (0.4) 200 4 (2.0) 5 (1.1)
Farmer / Lives on a farm3 Yes 26 3 (11.5) <0.000 20 2 (10,0) 0.009 1 0 0.840 2 (9.5)
No 451 1 (0.2) 241 1 (0.4) 199 4 (2.0) 5 (1.1)
Farmer / Lives on a farm /
Lives near to a farm (<5km)3
Yes 220 4 (1.8) 0.011 71 3 (4.2) 0.005 13 1 (7.7) 0.234 4 (4.8)
No 267 0 (0.0) 190 0 (0.0) 187 3 (1.6) 3 (0.8%)
1 Data are only presented for signiﬁcant factors collected in the study questionnaire (S1 File)
2 GPs: General Practitioners
3 Due to missing responses, the numbers do not always add up to the total
doi:10.1371/journal.pone.0139589.t002
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In the Netherlands the four cases of MRSA were found among three GPs, with one GP hav-
ing two cases of MRSA (2 out of a total of 55 nasal swabs). In Germany, three cases of MRSA
came from one GP (who reported a total of 63 nasal swabs), 3 cases came from one urologist
(100 nasal swabs) and one case from the other urologist (100 nasal swabs). We were not able to
link the MRSA cases epidemiologically (e.g. family members) as the data were anonymous.
Discussion
To our knowledge, this is the first study that has focused on the prevalence of MRSA carriage
in community outpatients who have used antibiotics in the last three months. Despite sampling
from this population and persons who lived in high-density livestock areas, the prevalence of
MRSA carriage was low in both countries: 0.8% in the Dutch GP patients, 1.1% in the German
GP outpatients and 2.0% in German urologist outpatients. The prevalence of S. aureus carriage
Table 3. MRSA cases by spa-type and region: Dutch region (Gelderland, Brabant and Limburg) and German region (North Rhine-Westphalia).
Country region
and type of
physicians
MRSA
spa
type
Sex/
age
Farmer/
Health
care
worker
Contact
with living
animals
Lives
on/
near
farm
Hospitalization in
the last six
months
Health reason for
which antibiotics
were prescribed
(previous three
months)
Antibiotic
group2
Antibiotic
speciﬁcation
Dutch region:
GP1
outpatients
(n = 4)
t011 M/80 No No Yes Yes Respiratory tract
infection
Broad-spectrum
penicillin
Amoxicillin/
Clavulanic acid
t011 F/40 Farmer No Yes No Skin and soft
tissue infection
Broad-spectrum
penicillin
Amoxicillin/
Clavulanic acid
t011 F/69 Farmer Cattle Yes No Respiratory tract
infection
Small-spectrum
penicillin
Amoxicillin
t011 F/69 Farmer Cattle Yes No Respiratory tract
infection
Broad-spectrum
penicillin
Amoxicillin/
Clavulanic acid
German
Region: GP
outpatients
(n = 3)
t034 F/29 HCW No Yes No Sinusitis/
Pharyngitis/
Laryngitis
Small-spectrum
penicillin
Amoxicillin
t034 M/40 Farmer/
HCW
Pigs Yes No Sinusitis/
Pharyngitis/
Laryngitis
Small-spectrum
penicillin
Amoxicillin
t011 F/75 Farmer Pigs Yes No Respiratory tract
infection
Small-spectrum
penicillin
Amoxicillin
German
Region:
Urologist
outpatients
(n = 4)
t032 F/73 No No No Yes Urinary tract
infection
Fluoroquinolones Nitrofurantoin
t10231 F/43 HCW No No Yes Urinary tract
infection
Cepahlosporin Ceftibuten
t003 M/69 No No No Yes Urinary tract
infection
Cepahlosporin Cefuroxime
t068 F/66 No No Yes No Urinary tract
infection
TMP/SMZ Cotrimoxazole
1 GP: General Practitioner
2 Based on the ﬁrst-reported antibiotic (93% of patients reported only one antibiotic in the previous 3 months): Broad-spectrum penicillin (amoxicillin/
clavulanic acid); Small-spectrum penicillin (benzylpenicillin, amoxicillin, feneticillin, ﬂucloxacillin); Cephalosporines (cefuroxime, cefpodoxime, ceftibuten,
ceﬁxime); TMP (trimethoprim) / SMZ (sulfamethoxazole)
doi:10.1371/journal.pone.0139589.t003
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(MSSA and MRSA) was 31% in the Netherlands and 24% in Germany, which is comparable to
the average prevalence in the general population and confirms appropriate technical retrieval
of the nasal swabs [10, 14].
We expected a higher prevalence of MRSA carriage in the German region, as there is a higher
density of antibiotic use in outpatient care in Germany (14.9 Daily Defined Doses per 1,000
inhabitants per day (DID) compared to 11.4 DID in the Netherlands [15]), there is a more fre-
quent use of fluoroquinolones among German patients which might be associated with
increased selective pressure [16], there are more aggressive MRSA search and destroy policies
implemented in Dutch healthcare facilities [10], and there is a higher density of inpatient care in
Germany which facilitates the inter-facility spread of MRSA (8.2 patient beds per 1000 inhabi-
tants in Germany vs. 4.7/1000 inhabitants in the Netherlands) [17]. This has been supported by
studies which have estimated that the incidence of episodes of MRSA-bacteremia was 57.6 per
1,000,000 inhabitants in Germany (North Rhine-Westhalia) compared to 1.8 episodes per
1,000,000 inhabitants in the Netherlands [18]. Moreover, the proportion of MRSA on all S.
aureus isolated from blood cultures was 15.4% in Germany and 1.3% in the Netherlands in 2012
[19]. Surprisingly, there were no significant differences in MRSA carriage between the outpa-
tient groups in the two countries, and when we only looked at GP patients the MRSA rates were
very similar: 1.1% in Germany compared to 0.8% in the Netherlands (p = 0.879).
Our findings show similarities and differences with other MRSA-prevalence studies that
have been carried out in the Netherlands and Germany in different study populations. The
prevalence of MRSA carriage detected in our study was comparable to the prevalence among
patients at admission to hospitals in a Dutch-German study in 2006 (0.5/100 patients in the
Netherlands and 1.6/100 patients in Germany) [20], but was higher compared to data from a
recent Dutch study which showed an MRSA prevalence of 0.11% at hospital admission [21].
MRSA carriage was also higher than a study undertaken in 2010 among healthy persons
attending their GPs in 9 countries across Europe, but this was expected as our study was carried
out among persons who had used antibiotics in the previous three months. Among healthy
persons attending their GP the prevalence rate was 0.2% in the Netherlands (n = 1073) and
ranged from 0% in Sweden to 0.4% in Belgium, Croatia, France and the United Kingdom (no
data for Germany) [14].
The factors that were significantly associated with MRSA colonization in both countries in
the GP outpatient populations were: being a farmer and living on or near (<5km) to a farm.
For example, persons who were farmers and/or lived on a farm had the highest MRSA preva-
lence on both sides of the border: 11.5% in the Dutch region (3 out of 26) and 10.0% in the Ger-
man region (2 out of 20) (Table 2). These results are similar to Van Cleef in the Netherlands
(26.5% of persons who reported contact with livestock were positive for MRSA) [6], and have
been shown in various studies before [22,23].
A number of review studies have found associations between antimicrobial consumption
and MRSA carriage that are dose-dependent [24, 25]. Our study found an association between
antibiotic usage (‘high’ usage (>2,500 mg) in the previous three months) and MRSA carriage
for GP patients in the Netherlands but not for the patients in Germany, although this might
have been linked to the small sample sizes in the two German patient groups (n = 261 for the
GP patients and 200 for the urologist patients).
Our study also confirmed that persons carrying MRSA spa types indicative for the LA-MRSA
clonal lineage CC398 (t011, t034) mostly (4 out of 7), but not exclusively, had a history of live-
stock contact. To some extent this confirmed recent findings that there is a certain proportion
of patients colonized with LA-MRSA for whom acquisition via direct animal contact seems
unlikely [5, 23]. For these patients, other sources like nosocomial acquisition (in this study one
healthcare worker carried MRSA t034) or indirect transmission routes should be considered.
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The higher rates of MRSA carriage in the German urologist outpatients, the different factors
associated with MRSA carriage, and the different clonal spread in this population (all four
strains were indicative of HA-MRSA), might be explained by a number of factors. The urolo-
gist outpatients come from a different area of North-West Germany, with lower levels livestock
farming (see Fig 1). The urologist outpatients are also a different population compared to the
GP outpatients in Germany: there were no farmers amongst these patients (versus 3.8% in GP
outpatients) and, importantly, 30% had been hospitalised in the previous 6 months (versus
16.1% for the GP outpatients; Table 1).
Our study had a number of limitations. One important limitation was that the study was
powered for 1000 patients in each country and we were only able to recruit 513 patients in the
Netherlands and 461 patients in Germany. This limited our ability to show a significant differ-
ence in the prevalence of MRSA in the two countries and, due to the very small number of
MRSA patients, prevented a more detailed statistical analysis (using multivariate analytical
approaches) to assess the factors associated with MRSA carriage. We also found that the outpa-
tient population participating in this study, i.e. outpatients with previous antibiotic use, was
not representative for the community. For example, the age of participants (58 years on the
Dutch, 50 and 58 years on the German side), was older than expected for the mean age of per-
sons in the community and 11.9% of the Dutch and 15.7% of the German (GP outpatients)
participants worked in the healthcare sector which exceeds national statistical data (Nether-
lands 3.5% [26] and Germany 6% [27]). Therefore, the comparability to other MRSA preva-
lence studies performed in the community is limited. Finally, our results for outpatient
urologists in Germany are based on patients from just two practices in an area of North Rhine-
Westphalia with lower pig-density rates. This limits the generalizability of the findings and
comparability of the data to the GP patients.
Conclusions
In conclusion, despite sampling from a population that used antibiotics in the previous three
months and lived in high-density livestock farming areas, the prevalence of MRSA carriage was
low in the border regions of both countries. This is a positive public health finding, supple-
mented by the fact that it appears that we did not find an increase in the MRSA carriage in the
Netherlands since an earlier study carried out in 2008–09 (2.4%) [6]. An important finding in
the outpatient GP populations was that all spa types were indicative of livestock-associated
MRSA and that the factors associated with carriage were being a farmer, and living on or near
to a farm. In contrast, all MRSA spa types were indicative of healthcare-associated MRSA in
the urologist outpatient population in Germany. Considering these results are only based on
data from two urologists, their generalizability needs to be treated with care, but we recom-
mend further research regarding the spread and risk factors for MRSA in this specific outpa-
tient population.
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